search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
EQUINE VETERINARY EDUCATION / AE / NOVEMBER 2020


615


Source of funding


A.L. Ziegler’s salary was funded by the UNC CGIBD Basic Science Research Training Fellowship (NIH T32 5T32DK007737) at the time of the manuscript preparation.


Authorship


Both authors took part in article design, interpretation of the literature, preparation of the manuscript and gave their final approval of the manuscript.


References


Atukorala, I. and Hunter, D.J. (2013) Valdecoxib: the rise and fall of a COX-2 inhibitor. Expert Opin. Pharmacother. 14, 1077-1086.


Bienhoff, S.E., Smith, E.S., Roycroft, L.M. and Roberts, E.S. (2012) Efficacy and safety of deracoxib for control of postoperative pain and inflammation associated with soft tissue surgery in dogs. Vet. Surg. 41, 336-344.


Blikslager, A.T. (1999) Do we need cyclooxygenase-2 inhibitors in equine practice? Compend. Contin. Educ. Pract. Vet. 21, 548-550.


Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M.B., Hawkey, C.J., Hochberg, M.C., Kvien, T.K. and Schnitzer, T.J. and VIGOR Study Group (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in cases with rheumatoid arthritis. VIGOR Study Group. N. Engl. J. Med. 343, 1520-1528, 2 p following 1528.


Clark, J.O. and Clark, T.P. (1999) Analgesia. Vet. Clin. North Am. Equine Pract. 15, 705-723.


Cook, V.L. and Blikslager, A.T. (2015) The use of nonsteroidal anti- inflammatory drugs in critically ill horses. J. Vet. Emerg. Crit. Care 25, 76-88.


Cook, V.L., Jones Shults, J., McDowell, M., Campbell, N.B., Davis, J.L. and Blikslager, A.T. (2008) Attenuation of ischaemic injury in the equine jejunum by administration of systemic lidocaine. Equine Vet. J. 40, 353-357.


Cook, V.L., Meyer, C.T., Campbell, N.B. and Blikslager, A.T. (2009) Effect of firocoxib or flunixin meglumine on recovery of ischemic- injured equine jejunum. Am. J. Vet. Res. 70, 992-1000.


Cox, S., Villarino, N., Sommardahl, C., Kvaternick, V., Zarabadiour, C., Siger, L., Yarbrough, J., Amicucci, A., Reed, K., Breeding, D. and Doherty, T. (2013) Disposition of firocoxib in equine plasma after an oral loading dose and a multiple dose regimen. Vet. J. 198, 382- 385.


Duz, M. (2019) Choice of non-steroidal anti-inflammatory drugs in equine colic. U. K. Vet. Equine 3, 6-10.


Duz, M., Marshall, J.F. and Parkin, T.D. (2019) Proportion of nonsteroidal anti-inflammatory drug prescription in equine practice. Equine Vet. J. 51, 147-153.


Elfenbein, J.R., Sanchez, L.C., Robertson, S.A., Cole, C.A. and Sams, R. (2009) Effect of detomidine on visceral and somatic nociception and duodenal motility in conscious adult horses. Vet Anaesth. Analg. 36, 162-172.


Ewert, K.M., Fessler, J.F., Templeton, C.B., Bottoms, G.D., Latshaw, H.S. and Johnson, M.A. (1985) Endotoxin-induced hematologic and blood chemical changes in ponies: effects of flunixin meglumine, dexamethasone, and prednisolone. Am. J. Vet. Res. 46, 24-30.


Fessler, J.F., Bottoms, G.D., Coppoc, G.L., Gimarc, S., Latshaw, H.S. and Noble, J.K. (1989) Plasma endotoxin concentrations in experimental and clinical equine subjects. Equine Vet. J. 21, Suppl. 7, 24-28.


Fogle, J., Jacob, M., Blikslager, A., Edwards, A., Wagner, B., Dean, K. and Fogle, C. (2016) Comparison of lipopolysaccharides and soluble CD14 measurement between clinically endotoxaemic and nonendotoxaemic horses. Equine Vet. J. 49, 155-159.


Freeman, D.E. (2019) Letter to the Editor: Multicentre, blinded, randomised clinical trial comparing the use of flunixin meglumine


with firocoxib in horses with small intestinal strangulating obstruction. Equine Vet. J. 51, 422.


Goodrich, L.R. and Nixon, A.J. (2006) Medical treatment of osteoarthritis in the horse - a review. Vet. J. 171, 51-69.


Hardee, M.M., Moore, J.N. and Hardee, G.E. (1986) Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses. Res. Vet. Sci. 4, 152-156.


Kim, T.W., Lebkowska-Wieruszewska, B., Owen, H., Yun, H.I., Kowalski, C.J. and Giorgi, M. (2014) Pharmacokinetic profiles of the novel COX-2 selective inhibitor cimicoxib in dogs. Vet. J. 200, 77-81.


Kim, T.W., Della Rocca, G., Di Salvo, A., Ryschanova, R., Sgorbini, M. and Giorgi, M. (2015) Evaluation of pharmacokinetic and pharmacodynamic properties of cimicoxib in fasted and fed horses. N. Z. Vet. J. 63, 92-97.


Knych, H.K. (2017) Nonsteroidal anti-inflammatory drug use in horses. Vet. Clin. North Am. Equine Pract. 33, 1-15.


Little, D., Brown, S.A., Campbell, N.B., Moeser, A.J., Davis, J.L. and Blikslager, A.T. (2007) Effects of the cyclooxygenase inhibitor meloxicam on recovery of ischemia-injured equine jejunum. Am. J. Vet. Res. 68, 614-624.


Marshall, J.F. and Blikslager, A.T. (2011) The effect of nonsteroidal anti- inflammatory drugs on the equine intestine. Equine Vet. J. 43, Suppl. 39, 140-144.


Mathews, K.A. (2000) Nonsteroidal anti-inflammatory analgesics. Indications and contraindications for pain management in dogs and cats. Vet. Clin. North Am. Small Anim. Pract. 30, 783-804, vi-vii.


Moore, J.N. (1988) Recognition and treatment of endotoxemia. Vet. Clin. North Am. Equine Pract. 4, 105-113.


Moore, J.N., Garner, H.E., Shapland, J.E. and Schaub, R.G. (1981a) Equine endotoxemia: an insight into cause and treatment. J. Am. Vet. Med. Assoc. 179, 473-477.


Moore, J.N., Garner, H.E., Shapland, J.E. and Hatfield, D.G. (1981b) Prevention of endotoxin-induced arterial hypoxaemia and lactic acidosis with flunixin meglumine in the conscious pony. Equine Vet. J. 13, 95-98.


Naylor, R.J., Taylor, A.H., Knowles, E.J., Wilford, S., Linnenkohl, W., Mair, T.S. and Johns, I.C. (2013) Comparison of flunixin meglumine and meloxicam for post-operative management of horses with strangulating small intestinal lesions. Equine Vet. J. 46, 427-434.


Payne-Johnson, M., Becskei, C., Chaudhry, Y. and Stegemann, M.R. (2015) Comparative efficacy and safety of mavacoxib and carprofen in the treatment of canine osteoarthritis. Vet. Rec. 176, 284.


Proudman, C.J., Smith, J.E., Edwards, G.B. and French, N.P. (2002a) Long-term survival of equine surgical colic cases. Part 1: patterns of mortality and morbidity. Equine Vet. J. 34, 432-437.


Proudman, C.J., Smith, J.E., Edwards, G.B. and French, N.P. (2002b) Long-term survival of equine surgical colic cases. Part 2: modelling postoperative survival. Equine Vet. J. 34, 438-443.


Reymond, N., Speranza, C., Gruet, P., Seewald, W. and King, J.N. (2012) Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial. J. Vet. Pharmacol. Ther. 35, 175-183.


Robertson, S.A., Sanchez, L.C., Merritt, A.M. and Doherty, T.J. (2005) Effect of systemic lidocaine on visceral and somatic nociception in conscious horses. Equine Vet. J. 37, 122-127.


Semrad, S.D. and Moore, J.N. (1987a) Effects of a specific thromboxane synthetase inhibitor in equine endotoxaemia. Res. Vet. Sci. 43, 137-142.


Semrad, S.D. and Moore, J.N. (1987b) Effects of multiple low doses of flunixin meglumine on repeated endotoxin challenge in the horse. Prostaglandins Leukot. Med. 27, 169-181.


Semrad, S.D., Hardee, G.E., Hardee, M.M. and Moore, J.N. (1985) Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses. Am. J. Vet. Res. 46, 2474- 2479.


Semrad, S.D., Hardee, G.E., Hardee, M.M. and Moore, J.N. (1987) Low dose flunixin meglumine: effects on eicosanoid production and


© 2019 EVJ Ltd


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88